Buscar resultados de ensayos clínicos
Chronic Inflammatory Demyelinating Polyneuropathy - 26 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Condición: Chronic Inflammatory Demyelinating Polyneuropathy Fecha: 2013-04-01 Intervenciones: Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Completed |
Nombre del estudio: Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Condición: Chronic Inflammatory Demyelinating Polyneuropathy Fecha: 2011-06-16 |
Completed |
Nombre del estudio: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy Condición: Chronic Inflammatory Demyelinating Polyneuropathy Fecha: 2010-08-18 Intervenciones: Biological: 10% liquid formulation of human immunoglobulin Other Name: IgPro10; Privigen |
Withdrawn |
Nombre del estudio: High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy Condición: Chronic Inflammatory Demyelinating Polyneuropathy Fecha: 2010-11-05 Intervenciones: Drug: Cyclophosphamide |
Active, not recruiting |
Nombre del estudio: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy Condición: Chronic Inflammatory Demyelinating Polyneuropathy Fecha: 2006-01-16 Intervenciones: Biological: hematopoietic stem cell transplantation Autologous hematopoietic stem cell transplantation |
Completed |
Nombre del estudio: Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy Condición:
Intervenciones: Drug: lipoic acid Subjects will be started on a single daily dose of 600 mg of alpha lipoic acid or plac |
Completed |
Nombre del estudio: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Condición:
|
Active, not recruiting |
Nombre del estudio: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Condición:
|
Recruiting |
Nombre del estudio: Subcutaneous Immunoglobulin for CIDP Condición: Chronic Inflammatory Demyelinating Polyneuropathy Fecha: 2014-12-12 Intervenciones: Drug: Immune Globulin Subcutaneous (Human) Patients who have CIDP and are on IVIG will be allowed in the |
Recruiting |
Nombre del estudio: IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements Condición: Chronic Inflammatory Demyelinating Polyneuropathy Fecha: 2015-03-13 Intervenciones: Drug: Intravenous Immunoglobulin The decision to treat with IVIg will be entirely at the discretion of t |